Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease - Lopez, A; Mounier, M; Bouvier, A M (Clin Gastroenterol Hepatol, 2014)
et al.